RTX vs TMO
RTX: RTX is a global leader in aerospace and defense, supplying critical technology ranging from commercial aircraft engines to advanced missile defense systems. TMO: Thermo Fisher Scientific is a global leader in serving science, providing an extensive portfolio of analytical instruments, laboratory equipment, and mission-critical consumables for the life sciences and healthcare industries.
Side-by-side fundamentals
| Metric | RTX | TMO | Edge |
|---|---|---|---|
| Price as of 2026-07-23 close | $209.16 | $572.32 | |
| Market cap as of 2026-07-25 | $286.6B | $207.4B | |
| P/E as of 2026-07-25 | 37.03 | 29.78 | TMO lower |
| PEG as of 2026-07-25 | 3.42 | 2.89 | TMO lower |
| Net margin as of 2026-07-25 | +8.3% | +15.0% | TMO higher |
| Gross margin as of 2026-07-25 | +20.4% | +41.0% | TMO higher |
| Operating margin as of 2026-07-25 | +11.2% | +17.6% | TMO higher |
| ROE as of 2026-07-25 | +11.8% | +13.3% | TMO higher |
| ROA as of 2026-07-25 | +4.5% | +6.3% | TMO higher |
| Debt / equity as of 2026-07-25 | 0.56 | 0.81 | RTX lower |
| Revenue growth (YoY) as of 2026-07-25 | +11.8% | +7.2% | RTX higher |
| Revenue CAGR (3y) SEC XBRL | +9.7% | -0.3% | RTX higher |
| Dividend yield as of 2026-07-25 | +1.4% | +0.3% | RTX higher |
| Dividend streak (yrs) SEC XBRL | 5 | 5 | Tie |
| Beta as of 2026-07-25 | 0.29 | 0.84 | |
| 1-year return as of 2026-07-23 close | +37.1% | +19.6% | RTX higher |
Fundamentals: Finnhub, as of 2026-07-25. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-23.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.